Home Newsletters Mesenchymal Cell News Mesenchymal Stem Cell Treatment Improves Outcome of COVID-19 Patients via Multiple Immunomodulatory...

Mesenchymal Stem Cell Treatment Improves Outcome of COVID-19 Patients via Multiple Immunomodulatory Mechanisms

0
MSC infusion reduced the levels of C-reactive protein, proinflammatory cytokines, and neutrophil extracellular traps, and promoted the maintenance of SARS-CoV-2-specific antibodies.
[Cell Research]
7992332 {7992332:BBBBBBBB} apa 50 1 168189 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version